Why the study?
Does preoperative high sensitive troponin I (hs-TnI) predict major adverse cardiac events (MACE) in elderly patients undergoing hip fracture surgery?
Does preoperative high sensitive troponin I (hs-TnI) predict major adverse cardiac events (MACE) in elderly patients undergoing hip fracture surgery?
Preoperative assessment of high-sensitivity troponin I may help predict 90-day major adverse cardiac events in elderly patients undergoing hip fracture surgery.
Supports routine preoperative hs-TnI screening for risk stratification in orthopedic trauma;.
OBJECTIVE: Cardiovascular complications contribute to postoperative morbidity and mortality in elderly hip fracture patients. Limited data are available regarding which preoperative risk factors predict cardiovascular course following hip fracture surgery (HFS). We used high sensitive troponin I (hs-TnI) assays and clinical parameters to identify preoperative risk factors associated with major adverse cardiac events (MACE) in elderly hip fracture patients. METHOD: From August 2014 to November 2016, 575 patients with hip fracture were enrolled in a retrospective, single-center registry. A total of 262 of these patients underwent HFS and hs-TnI assays. MACE was defined as postoperative all-cause deaths, heart failure (HF), new-onset atrial fibrillation (AF), myocardial infarction (MI) and cardiovascular re-hospitalization that occurred within 90 days postoperative. RESULTS: < 0.01). CONCLUSION: In elderly patients with hip fracture who undergo HFS, a preoperative assessment of hs-TnI may help the risk refinement of cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: